FIELD: biochemistry.
SUBSTANCE: invention relates to an antibody or antigen-binding fragment thereof, which specifically binds to a T14 polypeptide. Also disclosed is a kit for diagnosing a subject suffering from a neurodegenerative disorder, comprising said antibody, as well as a method of diagnosing a subject, suffering from a neurodegenerative disorder with the help of said antibody.
EFFECT: invention enables effective diagnosis of neurodegenerative disorder.
15 cl, 25 dwg, 3 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CANCER | 2017 |
|
RU2783416C2 |
| ANTIBODY AGAINST BETA-AMYLOID, ANTIGEN-BINDING FRAGMENT OF SAID ANTIBODY, AND APPLICATION THEREOF | 2019 |
|
RU2777844C1 |
| ANTIBODIES WHICH BIND TO SORTILIN AND INHIBIT THE BINDING OF PROGRANULIN | 2016 |
|
RU2735639C2 |
| AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF | 2020 |
|
RU2826004C2 |
| ANTIBODIES TO TAU AND THEIR USE | 2018 |
|
RU2787779C2 |
| METHODS FOR DETECTING FOLATE RECEPTOR 1 IN PATIENT SAMPLE | 2018 |
|
RU2759410C2 |
| RGMa BINDING PROTEIN AND ITS USE | 2016 |
|
RU2809500C2 |
| MONOCLONAL ANTIBODIES TO ALPHA-SYNUCLEIN FOR PREVENTING TAU-PROTEIN AGGREGATION | 2017 |
|
RU2760334C2 |
| CD47-ANTIGEN-BINDING UNIT AND ITS USE | 2018 |
|
RU2780859C2 |
| ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2788095C2 |
